Decisions

Every decision we've summarized — searchable, filterable, neutral.

May 22 2026
9th Cir. 25-4889 Unpublished

Castillo-Ortiz v. Blanche

The United States Court of Appeals for the Ninth Circuit denied a petition for review of a Board of Immigration Appeals decision affirming the denial of cancellation of removal. The court found substantial evidence supported the denial and that the petitioner failed to exhaust his challenge to a motion to suppress.

May 22 2026
Fed. Cir. 26-1685 Panel Decision

Arsenis v. United States Trustee

The United States Court of Appeals for the Federal Circuit transferred an appeal regarding a bankruptcy decision because it lacked jurisdiction. The court ordered the case moved to the United States Court of Appeals for the Third Circuit.

May 22 2026
Fed. Cir. 26-138 Panel Decision

In re Mark Ingraham

The United States Court of Appeals for the Federal Circuit denied a petition for a writ of mandamus seeking to compel the issuance of a summons. The court found the petitioner failed to meet the demanding standard required for such extraordinary relief.

May 21 2026
Fed. Cir. 25-1106 Panel Decision

Batiste v. Collins

The United States Court of Appeals for the Federal Circuit dismissed an appeal by a veteran seeking an earlier effective date for a special monthly pension. The court held it lacked jurisdiction because the appellant failed to identify any legal error by the Veterans Court.

May 21 2026
Fed. Cir. 24-2312 Panel Decision

Campo v. United States

The United States Court of Appeals for the Federal Circuit affirmed the dismissal of a takings claim brought by oyster farmers. The court held that Louisiana statutes subordinate oyster leases to government actions taken for coastal protection, preventing a cognizable property interest under the Fifth Amendment.

May 21 2026
Fed. Cir. 24-2297 Panel Decision

Otsuka Pharmaceutical Co., Ltd. v. Lupin Ltd.

The United States Court of Appeals for the Federal Circuit affirmed a district court judgment finding that Lupin Ltd. did not infringe Otsuka Pharmaceutical Co., Ltd. patents and that certain claims were invalid for obviousness. The court upheld the lower court's claim construction and factual findings regarding the synthesis process and expert testimony.